Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 Protein
about
Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses - Target Selection and Optimized ScreeningArrayPitope: Automated Analysis of Amino Acid Substitutions for Peptide Microarray-Based Antibody Epitope Mapping.Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaquesLinear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies.How human IgGs against myelin basic protein (MBP) recognize oligopeptides and MBP.Antibody Recognition of Immunodominant Vaccinia Virus Envelope Proteins.Antibody-Mediated Catalysis in Infection and Immunity.Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8.Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development.Characterization of murine antibody responses to vaccinia virus envelope protein A14 reveals an immunodominant antigen lacking of effective neutralization targets.
P2860
Q35760869-5832E161-D6B9-4544-A887-267BEA9729B2Q35941208-83E0CE5E-6C00-4D70-8270-329B74FF9061Q36251251-57864C83-5D1B-4CDD-A2EB-6F0B0EFE4891Q36756690-AB6DDD81-4407-407F-92C2-5A24A5CC67E6Q36811880-A1727752-4D52-468F-B041-DEFFFDB23D68Q37417618-40770689-539E-475A-9805-B1769BF37217Q38805503-9DA0FEE1-AB88-45E0-A9D2-56E60543D8B7Q39167579-268FF1D3-5FCB-4C7B-B61E-14FCAE758F96Q39412526-DC20A30B-FEA5-4B1A-8A3B-C1C5FA3F630BQ45325021-64A8B386-F471-4EA2-B721-6B99E0E28EE4Q47171892-412967B8-897A-4A35-A8F8-F8E9D7E050D0Q52725450-583314C0-C5EB-42B0-9743-8436CB47534B
P2860
Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 Protein
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Potent Neutralization of Vacci ...... of Vulnerability in L1 Protein
@ast
Potent Neutralization of Vacci ...... of Vulnerability in L1 Protein
@en
Potent Neutralization of Vacci ...... of Vulnerability in L1 Protein
@nl
type
label
Potent Neutralization of Vacci ...... of Vulnerability in L1 Protein
@ast
Potent Neutralization of Vacci ...... of Vulnerability in L1 Protein
@en
Potent Neutralization of Vacci ...... of Vulnerability in L1 Protein
@nl
prefLabel
Potent Neutralization of Vacci ...... of Vulnerability in L1 Protein
@ast
Potent Neutralization of Vacci ...... of Vulnerability in L1 Protein
@en
Potent Neutralization of Vacci ...... of Vulnerability in L1 Protein
@nl
P2093
P2860
P50
P356
P1433
P1476
Potent Neutralization of Vacci ...... of Vulnerability in L1 Protein
@en
P2093
Andrew Schlossman
April Frazier
Inbal Sela-Culang
Mark Buller
Michael H Matho
Ryan W Crump
Scott Parker
Shane Crotty
Thomas Kaever
P2860
P304
P356
10.1128/JVI.01491-14
P577
2014-10-01T00:00:00Z